SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Divi's Laboratories informs about newspaper publication

17 Jul 2024 Evaluate
Divi's Laboratories has enclosed copies of newspaper publications regarding notice of the 34th Annual General Meeting, e-voting and other information to the shareholders, including confirmation of having dispatched the Annual Report 2023-24 electronically. This notice is published on July 17, 2024, in Financial Express (English daily - All editions) and Andhra Prabha (Telugu daily - Hyderabad edition).

The above information is a part of company’s filings submitted to BSE.

Divis Lab Share Price

6228.95 -68.55 (-1.09%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×